Maik Klasen recognized in Annals of Blood’s 2026 outstanding authors series

Acumetis senior leader Maik Klasen, PhD, shares his perspective on scientific research, real-world evidence, and the role of academic publishing in advancing healthcare decision-making.

Annals of Blood has featured Maik Klasen, PhD, in its Interviews with Outstanding Authors (2026) series, recognizing contributors whose research and perspectives support continued discussion and advancement in the field.

As a partner and Insights and Analytics practice lead at Acumetis and a founding Managing Director of Adivo Associates, Maik brings experience spanning scientific research, biotechnology, and global life sciences consulting. His work focuses on applying clinical and real-world market evidence to inform commercial strategy, regulatory decision-making, market access, health economics, and reimbursement.

Connecting scientific evidence to real-world decisions

In the interview, Maik discusses the importance of academic research that goes beyond presenting findings to help inform practical decisions across healthcare and life sciences.

He highlights how rigorous research, transparent assumptions, and a clear understanding of uncertainty can support more informed decisions in clinical development, market access, and commercialization.

The conversation also explores the growing importance of real-world evidence, including electronic health records, claims data, and other emerging data sources, in understanding how therapies perform beyond controlled clinical settings.

Drawing on his recent research into plasma collection demand, Maik discusses how scientific and market evidence can inform planning as demand for plasma-derived products evolves and new mechanisms of action reshape the competitive landscape.

Advancing research through evidence and collaboration

Maik emphasizes the value of exploring unconventional data sources while maintaining scientific rigor and transparency. His perspective reinforces the importance of connecting research findings with the decisions they are intended to inform.

 Read Maik’s full interview in Annals of Blood to explore his perspectives on academic publishing, real-world evidence, and advancing scientific progress.